精神科药物市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00024007
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

预计精神药物市场在 2024 年至 2031 年期间的复合年增长率为 5.50%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告根据药物分类(第一代(典型)和第二代(非典型))进行了分析。报告还根据最终用途(精神分裂症、双相情感障碍、单相情感障碍、痴呆症等)进行了分析。全球分析进一步细分为区域和主要国家。范围涵盖了所有关键细分市场的全球、区域和国家层面的市场规模和预测。报告以美元为单位提供了上述分析和细分市场的价值。报告提供了主要市场参与者的市场状况的关键统计数据,并提供了市场趋势和机会。

报告目的

The Insight Partners 撰写的《精神药物市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

精神科药物市场细分

 

药物分类

  • 第一代
  • 第二代

最终用途

  • 精神分裂症
  • 躁郁症
  • 单相情感障碍
  • 失智
  • 其他的

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

精神药物市场:战略洞察

Psychiatric Medications Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

精神药物市场增长动力

  • 精神疾病患病率不断上升:精神疾病患病率不断上升,包括抑郁症、焦虑症和躁郁症,因此已成为精神药物市场的重要推动因素。现在人们更需要寻求治疗;因此,对有效药物治疗的需求不断增长。
  • 新疗法:随着全球老年人口的增加,大多数治疗阿尔茨海默病等神经系统疾病的疗法将推动精神药物市场的发展。这意味着老年人口的增加将导致需要药物治疗与这些疾病相关的认知和行为问题的患者数量相应增加。
  • 最近的诊断和认识:对心理健康认识的提高和技术的发展有利于更好地识别和治疗精神疾病。对心理健康问题的认识提高是医疗保健提供者和患者接受和使用精神药物的重要激励因素。

精神科药物市场未来趋势

  • 个性化医疗方法:个性化医疗已经进入精神药物市场;制造商正在积极研究个性化药物配方和给药方案,这些配方和方案将取决于特定的基因图谱、患者特征和治疗反应,以优化治疗效果。
  • 联合疗法:精神科药物与其他措施的联合疗法:这将推动一些联合疗法市场的新兴发展。这些疗法包括精神科药物与其他可用措施(无论是心理疗法还是生活方式改变)结合使用。这显然是一种针对这种复杂问题疾病的多个方面的整体方法,事实上,它扩展了可能的治疗解决方案领域。
  • 扩大适应症、标示外使用:公司正在寻找方法,将现有的精神科药物用于治疗其他几种精神疾病或标示外使用,用于其他治疗领域。这将进一步使患者可寻址成为可能,从而增强精神科药物市场的多样化。

精神科药物市场机会

  • 新兴市场扩张:亚洲、非洲和拉丁美洲的发展中地区将为精神科药物的生产提供巨大的增长前景。通过识别和满足这些市场中尚未满足的精神健康需求,并调整其产品以适应当地文化,同时兼顾价格承受能力,公司可以创造新的收入来源。
  • 数字营销和患者参与:这是精神科药物制造商开发与患者进行数字和创新营销互动的独特机会。这包括通过制定计划、媒体和远程医疗、教育资源和建立品牌来保持患者依从性。
  • 满足特定人群的未满足需求:确定特定患者群体(例如儿童、青少年或老年人)的未满足需求,这可能为精神科药物公司带来一些非常独特的可能性。适合年龄的配方可能有助于针对这些历来服务不足的患者群体进行此类药物的定向营销。

 

精神科药物市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响精神药物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的精神药物市场细分和地理位置。

Psychiatric Medications Market
  • 获取精神药物市场的区域特定数据

精神药物市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2025 - 2031)5.50%
史料2021-2023
预测期2025-2031
涵盖的领域按药品分类
  • 第一代
  • 第二代
按最终用途
  • 精神分裂症
  • 躁郁症
  • 单相情感障碍
  • 失智
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 阿尔克美斯
  • 礼来公司
  • 詹森全球服务有限公司(强生公司)
  • 艾尔建(AbbVie Inc.)
  • 辉瑞公司
  • 迈兰公司
  • 诺华公司
  • Axsome Therapeutics, Inc.
  • 阿卡迪亚制药公司

 

精神药物市场参与者密度:了解其对业务动态的影响

精神科药物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在精神药物市场运营的主要公司有:

  1. 阿尔克美斯
  2. 礼来公司
  3. 詹森全球服务有限公司(强生公司)
  4. 艾尔建(AbbVie Inc.)
  5. 辉瑞公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Psychiatric Medications Market

 

  • 了解精神药物市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:该报告全面涵盖了精神药物市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,精神科药物市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


Major driver boosting the psychiatric medications market market growth?

Rising Incidence of Sports Injuries is the major factors boosting the psychiatric medications market market growth

Who are the prominent players in psychiatric medications market market?

Medtronic, Johnson & Johnson Services Inc, Stryker, Zimmer Biomet, are the major companies operating in the psychiatric medications market market

Which is the fastest growing region in psychiatric medications market market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)

What years does this psychiatric medications market market cover?

The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)

Which region accounts for highest revenue share psychiatric medications market market?

The North America region accounts for highest revenue share psychiatric medications market market

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Alkermes
2. Eli Lilly and Company
3. Janssen Global Services, LLC (Johnson & Johnson)
4. Allergan (AbbVie Inc.)
5. Pfizer Inc.
6. Mylan N.V.
7. Novartis AG
8. Axsome Therapeutics, Inc.
9. Acadia Pharmaceuticals Inc.
10. Takeda Pharmaceutical Company Limited
11. GlaxoSmithKline plc
12. Otsuka Pharmaceutical Co, Ltd
13. AstraZeneca plc
psychiatric-medications-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.